Medicure Inc. (OTCMKTS:MCUJF – Get Free Report)’s stock price passed below its two hundred day moving average during trading on Thursday . The stock has a two hundred day moving average of $0.66 and traded as low as $0.51. Medicure shares last traded at $0.53, with a volume of 3,000 shares trading hands.
Medicure Price Performance
The firm has a market capitalization of $5.48 million, a price-to-earnings ratio of -3.75 and a beta of 0.98. The business’s 50-day moving average is $0.57 and its two-hundred day moving average is $0.66. The company has a debt-to-equity ratio of 0.03, a quick ratio of 1.64 and a current ratio of 2.03.
Medicure (OTCMKTS:MCUJF – Get Free Report) last announced its quarterly earnings results on Monday, November 25th. The company reported $0.05 earnings per share for the quarter. Medicure had a negative net margin of 9.62% and a negative return on equity of 10.12%.
About Medicure
Medicure Inc, a biopharmaceutical company, engages in the research, development, and commercialization of human therapies for the cardiovascular market. The company markets and distributes AGGRASTAT injection, a glycoprotein GP IIb/IIIa receptor antagonist for the treatment of acute coronary syndrome, including unstable angina and non-Q-wave myocardial infarction.
Further Reading
- Five stocks we like better than Medicure
- 3 Dividend Kings To Consider
- Unity Stock: Is a True Turnaround Finally Taking Shape?
- How Investors Can Identify and Successfully Trade Gap-Down Stocks
- DuPont’s Electronics Spinoff: The Start of Something Big
- The 3 Best Blue-Chip Stocks to Buy Now
- The Trade Desk Crashes on Earnings, But Growth Catalysts Persist
Receive News & Ratings for Medicure Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Medicure and related companies with MarketBeat.com's FREE daily email newsletter.
